Studies have focused on breast cancer, non-small cell lung cancer and squamous cell carcinoma of the head and neck, and there are indications that BAG-1 expression may also be altered in glioblastoma, cervical cancer and haemopoietic malignancies (Table 2). The gene discussed is BAG1; the disease is non-small cell lung carcinoma.